Literature DB >> 15221470

Antisense Tcf inhibits the neoplastic growth of liver cancer cells.

Ying Jiang1, Xin-Da Zhou, Yin-Kun Liu, Xiao-Wu Huang, Yan Zhao, Qiang Xue, Rui-Xa Sun, Jie Chen, Xin Wu.   

Abstract

PURPOSE: T cell transcription factors are nuclear effectors of the Wnt signaling transduction pathway and play crucial roles in embryonic and malignant development. Our previous study showed increased expression level of Tcf mRNA in liver cancer. In the present paper, antisense Tcf RNA was used to explore the possible therapeutic effect on liver cancer cells by interrupting the abnormal Wnt pathway.
METHODS: Antisense expression vectors containing the conserved sequence of Tcf cDNA were constructed and transfected into a human liver cancer cell line SMMC-7721. Tumorigenic potential was determined by cellular growth assay and tumor growth in nude mice.
RESULTS: The stable transfection of anti-sense Tcf in SMMC-7721 cells significantly reduced Tcf expression at both mRNA and protein levels compared with parental and mock-transfected cells. Antisense-mediated suppression of Tcf inhibited the in vitro proliferation and in vivo tumor formation ability. Furthermore, the apoptosis rate of antisense transfected cells was significantly higher than that of control, indicating that antisense RNA suppressed malignant growth by induction of apoptosis.
CONCLUSION: Our studies demonstrate the critical role of Wnt signaling pathway in the neoplastic growth of liver cancer cells and suggest that inhibition of Tcf activity with antisense Tcf RNA may be a potential new gene therapy method for liver cancer.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15221470     DOI: 10.1007/s00432-004-0580-9

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  44 in total

Review 1.  Wnt signaling and cancer.

Authors:  P Polakis
Journal:  Genes Dev       Date:  2000-08-01       Impact factor: 11.361

2.  Axil, a member of the Axin family, interacts with both glycogen synthase kinase 3beta and beta-catenin and inhibits axis formation of Xenopus embryos.

Authors:  H Yamamoto; S Kishida; T Uochi; S Ikeda; S Koyama; M Asashima; A Kikuchi
Journal:  Mol Cell Biol       Date:  1998-05       Impact factor: 4.272

3.  Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin.

Authors:  S Ikeda; S Kishida; H Yamamoto; H Murai; S Koyama; A Kikuchi
Journal:  EMBO J       Date:  1998-03-02       Impact factor: 11.598

4.  Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma.

Authors:  V Korinek; N Barker; P J Morin; D van Wichen; R de Weger; K W Kinzler; B Vogelstein; H Clevers
Journal:  Science       Date:  1997-03-21       Impact factor: 47.728

5.  Association of hTcf-4 gene expression and mutation with clinicopathological characteristics of hepatocellular carcinoma.

Authors:  Ying Jiang; Xin-Da Zhou; Yin-Kun Liu; Xin Wu; Xiao-Wu Huang
Journal:  World J Gastroenterol       Date:  2002-10       Impact factor: 5.742

6.  Apoptosis and APC in colorectal tumorigenesis.

Authors:  P J Morin; B Vogelstein; K W Kinzler
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-23       Impact factor: 11.205

7.  The F-box protein beta-TrCP associates with phosphorylated beta-catenin and regulates its activity in the cell.

Authors:  M Hart; J P Concordet; I Lassot; I Albert; R del los Santos; H Durand; C Perret; B Rubinfeld; F Margottin; R Benarous; P Polakis
Journal:  Curr Biol       Date:  1999-02-25       Impact factor: 10.834

8.  Identification of c-MYC as a target of the APC pathway.

Authors:  T C He; A B Sparks; C Rago; H Hermeking; L Zawel; L T da Costa; P J Morin; B Vogelstein; K W Kinzler
Journal:  Science       Date:  1998-09-04       Impact factor: 47.728

9.  A randomized phase II and pharmacokinetic study of the antisense oligonucleotides ISIS 3521 and ISIS 5132 in patients with hormone-refractory prostate cancer.

Authors:  Anthony W Tolcher; Leonard Reyno; Peter M Venner; Scott D Ernst; Malcolm Moore; Richard S Geary; Kim Chi; Sean Hall; Wendy Walsh; Andrew Dorr; Elizabeth Eisenhauer
Journal:  Clin Cancer Res       Date:  2002-08       Impact factor: 12.531

10.  Measurement of protein using bicinchoninic acid.

Authors:  P K Smith; R I Krohn; G T Hermanson; A K Mallia; F H Gartner; M D Provenzano; E K Fujimoto; N M Goeke; B J Olson; D C Klenk
Journal:  Anal Biochem       Date:  1985-10       Impact factor: 3.365

View more
  3 in total

Review 1.  Gene therapy of liver cancer.

Authors:  Ruben Hernandez-Alcoceba; Bruno Sangro; Jesus Prieto
Journal:  World J Gastroenterol       Date:  2006-10-14       Impact factor: 5.742

2.  Identification of genes regulated by Wnt/beta-catenin pathway and involved in apoptosis via microarray analysis.

Authors:  Moli Huang; Yihua Wang; Daochun Sun; Hongxia Zhu; Yanbing Yin; Wei Zhang; Shangbin Yang; Lanping Quan; Jinfeng Bai; Shengqi Wang; Quan Chen; Songgang Li; Ningzhi Xu
Journal:  BMC Cancer       Date:  2006-09-07       Impact factor: 4.430

3.  Selection and Characterization of a Novel DNA Aptamer, Apt-07S Specific to Hepatocellular Carcinoma Cells.

Authors:  Xiao-Xia Yu; Ke-Li Ge; Ning Liu; Jin-Yu Zhang; Mei-Lan Xue; Yin-Lin Ge
Journal:  Drug Des Devel Ther       Date:  2020-04-20       Impact factor: 4.162

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.